Amneal Pharmaceuticals, Inc., is a Delaware corporation. The company is a diversified global biopharmaceutical business that develops, manufactures, markets and distributes a broad portfolio of pharmaceuticals. It operates through three divisions: the general drug division, which includes retail generic drugs and injections; the specialty drug division, which focuses on brand-name drugs for central nervous system and endocrine diseases; and the AvKARE division, which provides distribution services for the US government and retail markets.
